|
|
| (11) | Number of the document | C 2330892 |
| (68) | Number of the document | 2330892 |
| (21) | Application number for Supplementary Protection Certificate | PA 2016 041 |
| (22) | Date of filing the application | 2016-12-16 |
| (41) | Date of publication of the application | 2017-01-10 |
| Date of publication of SPC | 2018-06-11 | |
| (24) | Date of coming into effect of SPC | 2029-01-08 |
| (71) |
Horizon Therapeutics, LLC,
150 S. Saunders Rd., Lake Forest IL 60045,
US
|
| (73) |
Immedica Pharma AB,
Norrtullsgatan 15, 113 29 Stockholm,
SE
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (93) | EU/1/15/1062, 2015-11-27 |
| (94) | 2030-12-01 |
| (95) | Glicerolio fenilbutiratas |
| SPC granted |